324 related articles for article (PubMed ID: 13677271)
1. Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.
Ohler L; Geissler K; Hinterberger W
Wien Klin Wochenschr; 2003 Aug; 115(13-14):537-46. PubMed ID: 13677271
[TBL] [Abstract][Full Text] [Related]
2. [Chronic myeloproliferative syndromes].
de Ozalla CB; García Suárez J
Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
[No Abstract] [Full Text] [Related]
3. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
5. Myeloproliferative syndromes: diagnosis and therapeutic options.
Hellmann A
Pol Arch Med Wewn; 2008 Dec; 118(12):756-60. PubMed ID: 19202955
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells (third of three parts).
Quesenberry P; Levitt L
N Engl J Med; 1979 Oct; 301(16):868-72. PubMed ID: 384249
[No Abstract] [Full Text] [Related]
7. The colony forming cell in the myeloproliferative disorders and aplastic anaemia.
Rickard KA; Brown RD; Wilkinson T; Kronenberg H
Scand J Haematol; 1979 Feb; 22(2):121-8. PubMed ID: 285455
[TBL] [Abstract][Full Text] [Related]
8. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
9. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
Lichtman MA
Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
[No Abstract] [Full Text] [Related]
10. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
12. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
Greenberg P; Mara B; Bax I; Brossel R; Schrier S
Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
[TBL] [Abstract][Full Text] [Related]
13. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
[TBL] [Abstract][Full Text] [Related]
14. Granulopoiesis in vitro and cytogenetic studies in patients with myelodysplastic syndromes, aplastic anemia and polycythemia vera.
Bianchi de Di Risio CC; Larripa I; Barbich M; Brieux de Salum S
Haematologica; 1983; 68(6):712-22. PubMed ID: 6421666
[No Abstract] [Full Text] [Related]
15. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry.
Spivak JL
Semin Hematol; 2003 Jan; 40(1 Suppl 1):1-5. PubMed ID: 12682874
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
Vilcu A; Hossu T; Popescu ID; Câmpeanu L
Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
[No Abstract] [Full Text] [Related]
18. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
19. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
20. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]